CMRX
NASDAQ
$8.54
Chimerix Inc (CMRX)
Chimerix, Inc., a developing-stage biopharmaceutical company, focuses on accelerating the advancement of various drugs that impact the lives of patients living with cancer and other serious diseases. The company is headquartered in Durham, North Carolina.
Sector:
Healthcare
Industry:
Biotechnology
Target: $8.53 (-0.12%)
Market Cap
$766M
Free Cash Flow Yield
-9.83%
Beta (5Y)
0.05
Price Chart
Valuation
Market Cap$766M
Forward P/E1.21
P/S3613.35
P/B6.30
Profitability
Total Revenue (TTM)$212K
Gross Profit (TTM)-$74M
EBITDA-$96M
Operating Margin-43074%
EPS-$0.99
Financial Health
Free Cash Flow Yield-9.83%
Growth & Risk
Revenue 5Y CAGR-54.73%
Beta (5Y)0.05
Sharpe Ratio1.51